NCT04036305View on ClinicalTrials.gov

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Active, not recruitingOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Ehlers-Danlos SyndromeAnesthesia, Local
Interventions
DRUG

0.9% Sodium Chloride Injection

All participants will be injected subcutaneously with a single 0.5ml dose

DRUG

Lidocaine Injection 2%

All participants will be injected subcutaneously with a single 0.5ml dose

DRUG

Bupivacaine Injection 0.5%

All participants will be injected subcutaneously with a single 0.5ml dose

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

University of Calgary

OTHER

lead

Vanderbilt University Medical Center

OTHER